Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.
Karajannis MA, Legault G, Fisher MJ, Milla SS, Cohen KJ, Wisoff JH, Harter DH, Goldberg JD, Hochman T, Merkelson A, Bloom MC, Sievert AJ, Resnick AC, Dhall G, Jones DT, Korshunov A, Pfister SM, Eberhart CG, Zagzag D, Allen JC.
Karajannis MA, et al. Among authors: fisher mj.
Neuro Oncol. 2014 Oct;16(10):1408-16. doi: 10.1093/neuonc/nou059. Epub 2014 May 6.
Neuro Oncol. 2014.
PMID: 24803676
Free PMC article.
Clinical Trial.